(Q53594098)
Statements
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. (English)
Eisenberg JD
Aitken ML
Dorkin HL
Harwood IR
Ramsey BW
Schidlow DV
Wilmott RW
Wohl ME
Fuchs HJ
Christiansen DH
Smith AL
1 July 1997
131
1 Pt 1
118-124
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference